EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

The role of polygenic risk in Alzheimer's disease prediction for African Americans

Christina G Hutten iD, Todd Beck, Denis Evans, Kumar B Rajan

Alzheimer's & Dementia · 2026

DOI: 10.1002/alz.71712 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Christina G Hutten und 3 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine-Epidemiology, Rush Institute for Healthy Aging, Rush University Medical Center, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Black or African American, Genetic Predisposition to Disease, Multifactorial Inheritance. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION African Americans (AAs) face a higher risk of Alzheimer's disease and related dementias (ADRD) than European Americans (EUs), yet the utility of polygenic risk scores (PRS) in AAs remains underexplored. METHODS A standardized dementia PRS was evaluated in the Chicago Health and Aging Project ( n = 4336; 61% AA) for associations with ADRD and cognitive trajectories over 8.4 years. RESULTS PRS predicted ADRD more strongly in EUs (c‐index 0.86) than AAs (0.77); however, it conferred higher risk in AAs (hazard ratio [HR] = 1.36, 95% confidence interval [CI]: 1.04–1.78) compared to EU (HR = 1.13, 95% CI: 0.88–1.44). The PRS remained predictive among AAs after apolipoprotein E ( APOE ) ε4 adjustment (HR = 1.53, 95% CI: 1.03–2.27). Higher PRS associated with lower baseline cognition and faster decline ( p < 0.05). DISCUSSION PRS conferred greater ADRD risk in AAs and comparable rates of cognitive decline, despite stronger discrimination in EUs, adding to the limited knowledge of genetic contributions to ADRD risk among AAs beyond APOE ε4 alleles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseBlack or African AmericanGenetic Predisposition to DiseaseMultifactorial InheritanceAgedAged, 80 and overFemaleHumansMaleApolipoprotein E4Genetic Risk ScoreRisk FactorsWhiteChicago

Stichwörter der Autor:innen

Alzheimer's disease and related dementiasadmixturecognitive declinediverse populationspolygenic risk scorerisk stratification

Substanzen

Apolipoprotein E4

Autor:innen und Institutionen

  • Internal Medicine-Epidemiology, Rush Institute for Healthy Aging, Rush University Medical Center, Chicago, Illinois, USA.

ORCID-Profile: Christina G Hutten

Förderung

  • NIA NIH HHS
  • National Institute on Aging

Zitieren

APA

Hutten, C. G., Beck, T., Evans, D., & Rajan, K. B. (2026). The role of polygenic risk in Alzheimer's disease prediction for African Americans. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71712

Vancouver

Hutten CG, Beck T, Evans D, Rajan KB. The role of polygenic risk in Alzheimer's disease prediction for African Americans. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71712

BibTeX
@article{Hutten2026,
  author = {Hutten, Christina G and Beck, Todd and Evans, Denis and Rajan, Kumar B},
  title = {The role of polygenic risk in Alzheimer's disease prediction for African Americans},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  doi = {10.1002/alz.71712}
}
Kostenlos starten →